SYK's Quality Score fell 1 point on Tue, Nov 3, to -2.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 6% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%.
| Holding it back | Below its 200-day since August |
| Latest filing | 8-K, Oct 29 |
Stryker Corporation filed an 8-K reporting a change of CEO
SYK closed −1.0% the next session (Oct 7).
Tue Nov 17: Jefferies 17th Annual London Global…Investor conference · date confirmed.
After its last 4 reports it closed -3.7% on average, higher 1 of 4 times.
Poorfor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. SYK scores -2 today, against a median of 2 over its last 20 recorded sessions.
SYK is #75 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 75 |
Net income over four quarters: SYK $3.73B, DXCM $1.00B, PEN $161M, BAX -$1.06B.
Expected to report Thu Jan 28, after the close (in 86 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“Organic net sales increased 7.7% in the quarter primarily driven by increased unit volume.”
SYK's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Organic net sales growth | 6.5% to 7.0% |
“The underlying fundamentals of the business remain strong, and we expect a solid performance in Q4 and good momentum heading into 2027.”
From its results filing (SEC filing · Oct 29)
Sales grew 12% a year over 5 years, fiscal 2020 to 2025.
Pays $3.52 a share a year.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Oct 29, 2026 | -7.6% | -6.4% | open |
| Jul 30, 2026 | -5.2% | -6.4% | -3.0% |
| Apr 30, 2026 | -0.6% | -6.5% | -6.6% |
Sales grew in six of the last seven years, to $25B in 2025. It made a profit in each of the eight years.
Its dividends come to 29% of its free cash flow.
| Dividend | $3.52 a share a year |
| Paid out | About $1.4B a year |
| Free cash flow | $4.7B |
| Record | Raised each of the last 5 years |
4 insiders sold $217M across 30 filings in the last 6 months. No open-market buys on record. The newest:
32 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: SYK is 1.2% of JEPI, 0.4% of VIG, and 0.3% of DGRO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
“In each of our product lines we compete with local and global companies.”
SYK scores -2 today, which Breakaway calls Poor. It is #75 of 85 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 6% on Oct 30, a down day for the market: the S&P 500 fell 2%, 71% of stocks fell, and medical device stocks a median 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SYK scores -2 today, which Breakaway calls Poor (below zero). That is #75 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SYK's -2.
4 insiders sold $217M across 30 filings in the last 6 months. No open-market buys on record. The newest is Dylan Bram Crotty, Group President, who sold $145K on Aug 21. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.